Anoctamin-1 — Drug Target
All drugs that target Anoctamin-1 — marketed and clinical-stage. Includes 2 drug classes acting on this target.
Drug classes
Antiprotozoal [EPC] · Antidiarrheal [EPC]
Marketed (2)
- Alinia · Romark · Antiprotozoal [EPC] · Infectious Disease
Alinia works by inhibiting the Anoctamin-1 ion channel, disrupting the parasite's ability to maintain its cellular environment. - Mytesi · Napo Pharms Inc · Antidiarrheal [EPC] · Infectious Disease
Mytesi works by blocking the action of a specific protein called anoctamin-1, which helps regulate the movement of water and electrolytes in the intestines.